These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2004-001035-32 NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001810-16 Intermediate and high risk localized , completely resected, gastrointestinal stromal tumors ( GIST) expressing KIT receptor: a controlled randomized trial on adjuvant Imatinib mesylate ( Glivec) versu... 2017-07-12 bad-data
Ongoing 2006-006446-33 Open-label trial of Imatinib in patients with Desmoid Tumor and Chondrosarcoma not-yet-due
Listed as ongoing, but also has a completion date 2007-002257-23 A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate. 2011-03-11 bad-data
Ongoing 2007-004396-19 Phase II, open label, non-randomized study of second or third line treatment with sorafenib (BAY 43-9006) in patients affected by relapsed high-grade osteosarcoma. not-yet-due
Listed as ongoing, but also has a completion date 2010-023484-17 LOCALIZED HIGH-RISK SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL IN ADULTS: AN INTEGRATING APPROACH COMPRISING STANDARD VS HISTOTYPE-TAILORED NEOADJUVANT CHEMOTHERAPY (ISG-STS 10-01) 2016-05-26 bad-data
Not reported 2011-000561-12 A phase II, open label, non-randomized study of second or third line treatment with the combination of sorafenib and everolimus in patients affected by relapsed and non-resectable high-grade osteos... 2015-06-19 due-trials
Ongoing 2011-001659-36 ABCB1/P-glycoprotein as biological marker for treatment of patient with high grade osteosarcoma not-yet-due
Completed, but no date Terminated 2012-001010-42 A multicenter, prospective, randomized clinical trial for patients with relapsed osteosarcoma bad-data
Ongoing 2012-005428-14 A Phase II study on Trabectedin in advanced retroperitoneal leiomyosarcoma and well differentiated/dedifferentiated liposarcoma not-yet-due
Ongoing 2013-001467-23 SAFETY AND ACTIVITY OF TRABECTEDIN AS FIRST LINE IN ADVANCED SOFT TISSUE SARCOMA (STS) PATIENTS UNFIT TO RECEIVE STANDARD CHEMOTHERAPY: A PROSPECTIVE PHASE II STUDY WITH CLINICAL AND MOLECULAR CORRELA... not-yet-due